Retrospective study evaluating the association between rosiglitazone use and clinical course of diabetic nephropathy: population-based study
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 13 Jul 2007 New trial record.